Showing results (121-130 of 979) with videos related to
Sort By:
Pageof 98
Current Drug Safety|March 20, 2012
Differences in medication adherence, satisfaction and clinical symptoms in schizophrenic outpatients taking different antipsychotic regimensWaleed M Sweileh, Manal S Ihbesheh, Ikhlas S Jarar, et al.Current Drug Safety|March 20, 2012
Safety of dipeptidyl peptidase 4 inhibitors for treatment of type 2 diabetesNasser MikhailCurrent Drug Safety|March 20, 2012
Successful desensitization of three patients with hypersensitivity reactions to omalizumabGregory Owens, Andrej PetrovCurrent Drug Safety|March 20, 2012
Safety of intravenous thrombolysis in ischemic stroke caused by left atrial myxomaMaurizio Acampa, Rossana Tassi, Francesca Guideri, et al.Current Drug Safety|January 10, 2017
Dispensing Patterns of Anxiolytics and Sedative-Hypnotics: A Feasibility Study Comparing Datasets from a Developed and a Developing Country (Australia and South Africa)Therese Kairuz, Ilse Truter, Laurence Rossato, et al.Current Drug Safety|August 6, 2013
MISSED PARACETAMOL (ACETAMINOPHEN) OVERDOSE DUE TO CONFUSION REGARDING DRUG NAMESDavid G Hewett, Jennifer Shields, W Stephen WaringCurrent Drug Safety|August 7, 2013
Adverse drug reaction labelling for atomoxetine, methylphenidate and modafinil: comparison of product information for oral formulations in Australia, Denmark and the United StatesLise Aagaard, Ebba Holme HansenCurrent Drug Safety|September 23, 2015
Incidence of Adverse Drug Reactions in Indian Hospitals: A Systematic Review of Prospective StudiesTejas K Patel, Parvati B PatelCurrent Drug Safety|September 23, 2015
A Case of Toxic Epidermal Necrolysis Secondary to Acetaminophen in a ChildMaría Á Pena, Sonia Pérez, Ma Concepción Zazo, et al.Current Drug Safety|October 15, 2015
Biologic Therapy in Psoriasis: Safety ProfileAnna Campanati, Giulia Ganzetti, K Giuliodori, et al.Pageof 98